Clinical Trial Update: Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating INCBB099280 as a pre-transplant therapy for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• INCBB099280

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: WITHDRAWN